Since AR signaling plays a crucial role in prostate cancer progression, these interactions suggest that ALD may effectively disrupt AR-driven pathways, thereby inhibiting PC3 and DU145 cell proliferation and survival (44). Here, AR is linked to prostate carcinoma.